{
    "nct_id": "NCT03507608",
    "official_title": "Randomized Trial Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression",
    "inclusion_criteria": "* Histologically confirmed prostate cancer\n* At least one biopsy core with Gleason 7 or higher disease\n* The patient has decided to undergo brachytherapy plus androgen suppression as treatment modality for his prostate cancer (with or without supplemental external beam radiation)\n* Suitable volume of disease for biopsy:\n* clinically palpable disease corresponding to (ipsilateral to) any involved core on biopsy\n* Signed study-specific consent form prior to registration\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 100 Years",
    "exclusion_criteria": "* Known hypersensitivity or allergic response to flutamide\n* Severe hepatic impairment\n* Major medical or psychiatric illness which, in the investigator's opinion, would prevent completion of treatment and would interfere with follow up.",
    "miscellaneous_criteria": ""
}